The Truqap-Faslodex treatment combination offers “more options” for some patients with HR-positive, HER2-negative breast cancer, an expert told CURE®.

Fulvestrant Injection is a therapeutic equivalent generic for Faslodex® (fulvestrant) approved by the U.S. Food and Drug Administration. Fulvestrant Injection is indicated for: ...

Positive high-level results from the CAPItello-291 Phase III trial showed that AstraZeneca’ s capivasertib in combination with FASLODEX ® demonstrated a statistically significant and clinically ...